Authors
Yu Long, Yuanyuan Wu, Xiaoqiu Li, Huiyi Feng, Jie Deng, Nan Li
Published in
Journal of materials chemistry. B. Nov 18, 2026. Epub Nov 18, 2026.
Abstract
Ischemic stroke presents a major therapeutic challenge, where modulating microglial polarization is a promising strategy. To enhance the brain delivery and targeting of Chuanxiong essential oil (CXEO), we developed a biomimetic nanoplatform, CXEO-loaded liposomes hybridized with M2-like-microglia membranes (CXEO-LP@M2M). In vitro BV2 cell experiments assessed uptake and inflammatory response. In vivo evaluation used a BCCAO/R mouse model to investigate targeting, anti-inflammatory, anti-oxidative, and neuroprotective effects. CXEO-LP@M2M showed stable properties with a 150.6 ± 2.80 nm particle size and -12 ± 2.52 mV zeta potential. SDS-PAGE, western blot and dual-dye colocalization supported the retention of M2-like microglial membrane proteins on CXEO-LP@M2M. The encapsulation efficiency and drug loading were 80.19% and 2.22%. The formulation showed acceptable storage and colloidal stability at 4 °C, and its release was slower than that of free CXEO and similar to that of CXEO-LP. The cellular uptake of CXEO-LP@M2M by BV2 cells was higher than that of CXEO-LP. In vitro, CXEO-LP@M2M significantly reduced TNF-α, IL-1β, and IL-6 levels and modulated microglia polarization. In vivo, it alleviated neurological deficits, brain edema, and histopathological changes, reduced inflammatory and oxidative stress markers, and promoted M2-like polarization. CXEO-LP@M2M combines cell membrane delivery and nano-carrier systems, showing stability, safety, and efficient brain targeting in the present models. The M2-like-microglia membrane modification was intended to enhance microglial recognition and uptake, while nasal delivery may help bypass the blood-brain barrier. This study highlights CXEO-LP@M2M as a potential early intervention/protective strategy for ischemic stroke by combining biomimetic delivery with the modulation of neuroinflammation.
PMID:
43049768
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 2
- Comments 0